Quantcast
POLITICO politico.eu 10 Jan, 2022 13:45 am

British company pulls rapid COVID-19 test over Omicron detection concerns – POLITICO

British company pulls rapid COVID-19 test over Omicron detection concerns – POLITICO
Biotech company Avacta’s decision comes amid concerns test isn’t sensitive enough to pick up infection with newest coronavirus variant.

The decision comes amid concerns that antigen tests developed before the arrival of the Omicron variant aren't accurate enough with the new variant, which contains a large number of mutations.Antigen tests are less accurate than PCR tests, but can be purchased over the counter and don't require a lab technician to carry them out.Health experts worry that "false negative" antigen tests could mean that people are returning to the workplace while still infectious.British biotech Avacta is withdrawing its rapid antigen test from the market over concerns that the test isn't sensitive enough to detect cases of the Omicron variant that now make up the vast majority of infections in the U.

Avacta said that it will pause the sale of its rapid tests as it redesigns the product to make sure it is able to adequately detect cases of the Omicron variant.The rapid test was able to detect instances of the variant in cases where there was a high viral load.

Read full story at politico.eu